Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 98

1.

Randomized Phase II Trial of Cisplatin and Etoposide in Combination With Veliparib or Placebo for Extensive-Stage Small-Cell Lung Cancer: ECOG-ACRIN 2511 Study.

Owonikoko TK, Dahlberg SE, Sica GL, Wagner LI, Wade JL 3rd, Srkalovic G, Lash BW, Leach JW, Leal TB, Aggarwal C, Ramalingam SS.

J Clin Oncol. 2019 Jan 20;37(3):222-229. doi: 10.1200/JCO.18.00264. Epub 2018 Dec 5.

PMID:
30523756
2.

Molecular Characterization of Malignant Mesothelioma: Time for New Targets?

Aggarwal C, Albelda SM.

Cancer Discov. 2018 Dec;8(12):1508-1510. doi: 10.1158/2159-8290.CD-18-1181.

PMID:
30510013
3.

Cisplatin versus cetuximab with definitive concurrent radiotherapy for head and neck squamous cell carcinoma: An analysis of veterans health affairs data.

Bauml JM, Vinnakota R, Anna Park YH, Bates SE, Fojo T, Aggarwal C, Di Stefano J, Knepley C, Limaye S, Mamtani R, Wisnivesky J, Damjanov N, Langer CJ, Cohen RB, Sigel K.

Cancer. 2018 Oct 20. doi: 10.1002/cncr.31816. [Epub ahead of print]

PMID:
30341983
4.

Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in Metastatic Non-Small Cell Lung Cancer.

Aggarwal C, Thompson JC, Black TA, Katz SI, Fan R, Yee SS, Chien AL, Evans TL, Bauml JM, Alley EW, Ciunci CA, Berman AT, Cohen RB, Lieberman DB, Majmundar KS, Savitch SL, Morrissette JJD, Hwang WT, Elenitoba-Johnson KSJ, Langer CJ, Carpenter EL.

JAMA Oncol. 2018 Oct 11. doi: 10.1001/jamaoncol.2018.4305. [Epub ahead of print]

PMID:
30325992
5.

Mumps outbreak investigation in Jaisalmer, Rajasthan, India, June-September 2016.

Moghe CS, Goel P, Singh J, Nayak NR, Dhuria M, Jain R, Yadav R, Saroha E, Sodha SV, Aggarwal CS, Venkatesh S.

J Med Virol. 2019 Mar;91(3):347-350. doi: 10.1002/jmv.25324. Epub 2018 Oct 31.

PMID:
30252936
6.

Immunotherapy Targeting HPV16/18 Generates Potent Immune Responses in HPV-Associated Head and Neck Cancer.

Aggarwal C, Cohen RB, Morrow MP, Kraynyak KA, Sylvester AJ, Knoblock DM, Bauml JM, Weinstein GS, Lin A, Boyer J, Sakata L, Tan S, Anton A, Dickerson K, Mangrolia D, Vang R, Dallas M, Oyola S, Duff S, Esser M, Kumar R, Weiner D, Csiki I, Bagarazzi ML.

Clin Cancer Res. 2019 Jan 1;25(1):110-124. doi: 10.1158/1078-0432.CCR-18-1763. Epub 2018 Sep 21.

PMID:
30242022
7.

Cisplatin Every 3 Weeks Versus Weekly With Definitive Concurrent Radiotherapy for Squamous Cell Carcinoma of the Head and Neck.

Bauml JM, Vinnakota R, Anna Park YH, Bates SE, Fojo T, Aggarwal C, Limaye S, Damjanov N, Di Stefano J, Ciunci C, Genden EM, Wisnivesky JP, Ferrandino R, Mamtani R, Langer CJ, Cohen RB, Sigel K.

J Natl Cancer Inst. 2018 Sep 18. doi: 10.1093/jnci/djy133. [Epub ahead of print]

PMID:
30239887
8.

Diversity and Tissue Preference of Osmotolerant Bacterial Endophytes Associated with Pearl Millet Genotypes Having Differential Drought Susceptibilities.

Manjunatha BS, Paul S, Aggarwal C, Bandeppa S, Govindasamy V, Dukare AS, Rathi MS, Satyavathi CT, Annapurna K.

Microb Ecol. 2018 Sep 12. doi: 10.1007/s00248-018-1257-2. [Epub ahead of print]

PMID:
30209586
9.

Phase Ib study of pevonedistat, a NEDD8-activating enzyme inhibitor, in combination with docetaxel, carboplatin and paclitaxel, or gemcitabine, in patients with advanced solid tumors.

Lockhart AC, Bauer TM, Aggarwal C, Lee CB, Harvey RD, Cohen RB, Sedarati F, Nip TK, Faessel H, Dash AB, Dezube BJ, Faller DV, Dowlati A.

Invest New Drugs. 2018 May 21. doi: 10.1007/s10637-018-0610-0. [Epub ahead of print]

PMID:
29781056
10.

Combination Immunotherapy in Non-small Cell Lung Cancer.

Marmarelis ME, Aggarwal C.

Curr Oncol Rep. 2018 May 8;20(7):55. doi: 10.1007/s11912-018-0697-7. Review.

PMID:
29740718
11.

Radiologic Pseudoprogression during Anti-PD-1 Therapy for Advanced Non-Small Cell Lung Cancer.

Katz SI, Hammer M, Bagley SJ, Aggarwal C, Bauml JM, Thompson JC, Nachiappan AC, Simone CB 2nd, Langer CJ.

J Thorac Oncol. 2018 Jul;13(7):978-986. doi: 10.1016/j.jtho.2018.04.010. Epub 2018 May 5.

PMID:
29738824
12.

Thoracic Imaging of Non-Small Cell Lung Cancer Treated With Anti-programmed Death Receptor-1 Therapy.

Hammer M, Bagley S, Aggarwal C, Bauml J, Nachiappan AC, Simone CB 2nd, Langer C, Katz SI.

Curr Probl Diagn Radiol. 2018 Jan 31. pii: S0363-0188(17)30261-X. doi: 10.1067/j.cpradiol.2018.01.005. [Epub ahead of print]

PMID:
29573843
13.

Phase I Study of Intrapleural Gene-Mediated Cytotoxic Immunotherapy in Patients with Malignant Pleural Effusion.

Aggarwal C, Haas AR, Metzger S, Aguilar LK, Aguilar-Cordova E, Manzanera AG, Gómez-Hernández G, Katz SI, Alley EW, Evans TL, Bauml JM, Cohen RB, Langer CJ, Albelda SM, Sterman DH.

Mol Ther. 2018 May 2;26(5):1198-1205. doi: 10.1016/j.ymthe.2018.02.015. Epub 2018 Feb 21.

PMID:
29550074
14.

Corrigendum: Fine tuning chloroplast movements through physical interactions between phototropins.

Sztatelman O, Labuz J, Hermanowicz P, Banas AK, Bazant A, Zglobicki P, Aggarwal C, Nadzieja M, Krzeszowiec W, Strzalka W, Gabrys H.

J Exp Bot. 2018 Apr 9;69(8):2173. doi: 10.1093/jxb/ery008. No abstract available.

15.

Circulating tumor cells as a predictive biomarker in patients with small cell lung cancer undergoing chemotherapy.

Aggarwal C, Wang X, Ranganathan A, Torigian D, Troxel A, Evans T, Cohen RB, Vaidya B, Rao C, Connelly M, Vachani A, Langer C, Albelda S.

Lung Cancer. 2017 Oct;112:118-125. doi: 10.1016/j.lungcan.2017.08.008. Epub 2017 Aug 12.

PMID:
29191584
16.

The Role of Advanced Imaging in Assessing Response to Definitive Chemoradiation Before Prophylactic Cranial Irradiation in Limited-Stage Small-Cell Lung Cancer.

Kesarwala AH, Lu DJ, Xanthopoulos E, Apisarnthanarax S, Cengel KA, Evans TL, Aggarwal C, Cohen RB, Langer CJ, Rengan R, Simone CB 2nd.

Clin Lung Cancer. 2018 Mar;19(2):e205-e209. doi: 10.1016/j.cllc.2017.10.001. Epub 2017 Oct 12.

PMID:
29153967
17.

Etirinotecan Pegol (NKTR-102) in Third-line Treatment of Patients With Metastatic or Recurrent Non-Small-cell Lung Cancer: Results of a Phase II Study.

Aggarwal C, Cohen RB, Yu E, Hwang WT, Bauml JM, Alley E, Evans TL, Langer CJ.

Clin Lung Cancer. 2018 Mar;19(2):157-162. doi: 10.1016/j.cllc.2017.10.007. Epub 2017 Oct 19.

PMID:
29129435
18.

6,4-PP Photolyase Encoded by AtUVR3 is Localized in Nuclei, Chloroplasts and Mitochondria and its Expression is Down-Regulated by Light in a Photosynthesis-Dependent Manner.

Katarzyna Banas A, Hermanowicz P, Sztatelman O, Labuz J, Aggarwal C, Zglobicki P, Jagiello-Flasinska D, Strzalka W.

Plant Cell Physiol. 2018 Jan 1;59(1):44-57. doi: 10.1093/pcp/pcx159.

PMID:
29069446
19.

Emerging uses of circulating tumor DNA in advanced stage non-small cell lung cancer.

Marmarelis M, Thompson JC, Aggarwal C, Evans TL, Carpenter E, Cohen RB, Langer CJ, Bauml J.

Ann Transl Med. 2017 Sep;5(18):380. doi: 10.21037/atm.2017.07.29. Review.

20.

Prospective study of proton-beam radiation therapy for limited-stage small cell lung cancer.

Rwigema JM, Verma V, Lin L, Berman AT, Levin WP, Evans TL, Aggarwal C, Rengan R, Langer C, Cohen RB, Simone CB 2nd.

Cancer. 2017 Nov 1;123(21):4244-4251. doi: 10.1002/cncr.30870. Epub 2017 Jul 5.

21.

Temporally Factorized Network Modeling for Evolutionary Network Analysis.

Yu W, Aggarwal CC, Wang W.

Proc Int Conf Web Search Data Min. 2017 Feb;2017:455-464. doi: 10.1145/3018661.3018669.

22.

Treatment Paradigms for Advanced Non-Small Cell Lung Cancer at Academic Medical Centers: Involvement in Clinical Trial Endpoint Design.

Aggarwal C, Borghaei H.

Oncologist. 2017 Jun;22(6):700-708. doi: 10.1634/theoncologist.2016-0345. Epub 2017 Apr 13. Review.

23.

Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer.

Bagley SJ, Kothari S, Aggarwal C, Bauml JM, Alley EW, Evans TL, Kosteva JA, Ciunci CA, Gabriel PE, Thompson JC, Stonehouse-Lee S, Sherry VE, Gilbert E, Eaby-Sandy B, Mutale F, DiLullo G, Cohen RB, Vachani A, Langer CJ.

Lung Cancer. 2017 Apr;106:1-7. doi: 10.1016/j.lungcan.2017.01.013. Epub 2017 Jan 25.

PMID:
28285682
24.

Unsupervised exercise in survivors of human papillomavirus related head and neck cancer: how many can go it alone?

Bauml J, Kim J, Zhang X, Aggarwal C, Cohen RB, Schmitz K.

J Cancer Surviv. 2017 Aug;11(4):462-468. doi: 10.1007/s11764-017-0604-5. Epub 2017 Feb 13.

PMID:
28194641
25.

Characterization of putative virulence factors of Serratia marcescens strain SEN for pathogenesis in Spodoptera litura.

Aggarwal C, Paul S, Tripathi V, Paul B, Khan MA.

J Invertebr Pathol. 2017 Feb;143:115-123. doi: 10.1016/j.jip.2016.12.004. Epub 2016 Dec 18.

PMID:
27993620
26.

Pretreatment Red Blood Cell Total Folate Concentration Is Associated With Response to Pemetrexed in Stage IV Nonsquamous Non-Small-cell Lung Cancer.

Bagley SJ, Vitale S, Zhang S, Aggarwal C, Evans TL, Alley EW, Cohen RB, Langer CJ, Blair IA, Vachani A, Whitehead AS.

Clin Lung Cancer. 2017 Mar;18(2):e143-e149. doi: 10.1016/j.cllc.2016.10.010. Epub 2016 Oct 26.

27.

How Patients View Lung Cancer Screening. The Role of Uncertainty in Medical Decision Making.

Schapira MM, Aggarwal C, Akers S, Aysola J, Imbert D, Langer C, Simone CB 2nd, Strittmatter E, Vachani A, Fraenkel L.

Ann Am Thorac Soc. 2016 Nov;13(11):1969-1976.

28.

P2.39: Long-Term OS for Patients With Advanced NSCLC Enrolled in the KEYNOTE-001 Study of Pembrolizumab: Track: Immunotherapy.

Ramalingam S, Hui R, Gandhi L, Carcereny E, Felip E, Ahn MJ, Eder JP, Balmanoukian AS, Leighl N, Aggarwal C, Horn L, Patnaik A, Middleton GW, Gubens M, Hellmann M, Soria JC, Lubiniecki GM, Zhang J, Piperdi B, Garon EB.

J Thorac Oncol. 2016 Oct;11(10S):S241-S242. doi: 10.1016/j.jtho.2016.08.110. Epub 2016 Sep 22. No abstract available.

29.

Early detection of pemetrexed-induced inhibition of thymidylate synthase in non-small cell lung cancer with FLT-PET imaging.

Chen X, Yang Y, Berger I, Khalid U, Patel A, Cai J, Farwell MD, Langer C, Aggarwal C, Albelda SM, Katz SI.

Oncotarget. 2017 Apr 11;8(15):24213-24223. doi: 10.18632/oncotarget.12085.

30.

DNA-based immunotherapy for HPV-associated head and neck cancer.

Aggarwal C.

Immunotherapy. 2016 Oct;8(10):1187-92. doi: 10.2217/imt-2016-0055.

PMID:
27605067
31.

Detection of Therapeutically Targetable Driver and Resistance Mutations in Lung Cancer Patients by Next-Generation Sequencing of Cell-Free Circulating Tumor DNA.

Thompson JC, Yee SS, Troxel AB, Savitch SL, Fan R, Balli D, Lieberman DB, Morrissette JD, Evans TL, Bauml J, Aggarwal C, Kosteva JA, Alley E, Ciunci C, Cohen RB, Bagley S, Stonehouse-Lee S, Sherry VE, Gilbert E, Langer C, Vachani A, Carpenter EL.

Clin Cancer Res. 2016 Dec 1;22(23):5772-5782. Epub 2016 Sep 6.

32.

Fine tuning chloroplast movements through physical interactions between phototropins.

Sztatelman O, Łabuz J, Hermanowicz P, Banaś AK, Bażant A, Zgłobicki P, Aggarwal C, Nadzieja M, Krzeszowiec W, Strzałka W, Gabryś H.

J Exp Bot. 2016 Sep;67(17):4963-78. doi: 10.1093/jxb/erw265. Epub 2016 Jul 12.

33.

Joint Intermodal and Intramodal Label Transfers for Extremely Rare or Unseen Classes.

Guo-Jun Qi, Wei Liu, Aggarwal C, Huang T.

IEEE Trans Pattern Anal Mach Intell. 2017 Jul;39(7):1360-1373. doi: 10.1109/TPAMI.2016.2587643. Epub 2016 Jul 7.

PMID:
27392343
34.

Imaging for the Pretreatment Staging of Small cell Lung Cancer: A Systematic Review.

Mitchell MD, Aggarwal C, Tsou AY, Torigian DA, Treadwell JR.

Acad Radiol. 2016 Aug;23(8):1047-56. doi: 10.1016/j.acra.2016.03.017. Epub 2016 May 31. Review.

PMID:
27259379
35.

Immunotherapy for head and neck cancer: latest developments and clinical potential.

Bauml JM, Cohen RB, Aggarwal C.

Ther Adv Med Oncol. 2016 May;8(3):168-75. doi: 10.1177/1758834016631529. Epub 2016 Feb 16. Review.

36.

Imaging for the Pretreatment Staging of Small Cell Lung Cancer [Internet].

Treadwell JR, Mitchell MD, Tsou A, Torigian D, Aggarwal C, Schoelles KM.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Apr.

37.

Analysis of the Relationship Between Response to Chemotherapy and Response to Radiation Therapy in Patients With Non-Small Cell Lung Cancer Receiving Sequential Treatment.

Maquilan G, Grover S, Xanthopoulos E, Evans TL, Aggarwal C, Langer CJ, Cohen RB, Stevenson JP, Simone CB 2nd, Rengan R.

Am J Clin Oncol. 2018 Apr;41(4):391-395. doi: 10.1097/COC.0000000000000288.

PMID:
27100960
38.

Survival outcome according to KRAS mutation status in newly diagnosed patients with stage IV non-small cell lung cancer treated with platinum doublet chemotherapy.

Brady AK, McNeill JD, Judy B, Bauml J, Evans TL, Cohen RB, Langer C, Vachani A, Aggarwal C.

Oncotarget. 2015 Oct 6;6(30):30287-94. doi: 10.18632/oncotarget.4711.

39.

Arabidopsis PCNAs form complexes with selected D-type cyclins.

Strzalka WK, Aggarwal C, Krzeszowiec W, Jakubowska A, Sztatelman O, Banas AK.

Front Plant Sci. 2015 Jul 17;6:516. doi: 10.3389/fpls.2015.00516. eCollection 2015.

40.

Clinical Applications of Natriuretic Peptides in Assessment of Valvular Heart Disease.

Sharma A, Ahmed V, Garg A, Aggarwal C.

Dis Markers. 2015;2015:807861. doi: 10.1155/2015/807861. Epub 2015 Jul 22. Review.

41.

Biomarkers to enhance accuracy and precision of prediction of short-term and long-term outcome after spontaneous intracerebral haemorrhage: a study protocol for a prospective cohort study.

Kumar A, Kumar P, Misra S, Sagar R, Kathuria P, Vibha D, Vivekanandhan S, Garg A, Kaul B, Raghvan S, Gorthi SP, Dabla S, Aggarwal CS, Prasad K.

BMC Neurol. 2015 Aug 12;15:136. doi: 10.1186/s12883-015-0384-3.

42.

A phase 1 safety study of veliparib combined with cisplatin and etoposide in extensive stage small cell lung cancer: A trial of the ECOG-ACRIN Cancer Research Group (E2511).

Owonikoko TK, Dahlberg SE, Khan SA, Gerber DE, Dowell J, Moss RA, Belani CP, Hann CL, Aggarwal C, Ramalingam SS.

Lung Cancer. 2015 Jul;89(1):66-70. doi: 10.1016/j.lungcan.2015.04.015. Epub 2015 May 8.

43.

Identification of Quorum-Sensing Inhibitors Disrupting Signaling between Rgg and Short Hydrophobic Peptides in Streptococci.

Aggarwal C, Jimenez JC, Lee H, Chlipala GE, Ratia K, Federle MJ.

MBio. 2015 May 12;6(3):e00393-15. doi: 10.1128/mBio.00393-15.

44.

Rare Complex Mutational Profile in an ALK Inhibitor-resistant Non-small Cell Lung Cancer.

Azzato EM, Deshpande C, Aikawa V, Aggarwal C, Alley E, Jacobs B, Morrissette J, Daber R.

Anticancer Res. 2015 May;35(5):3007-12.

PMID:
25964588
45.

Multifocal pyomyositis in a young immunocompromised with normal CD4 count.

Kalal C, Aggarwal C, Rajbhoj A, Bhagra A.

J Assoc Physicians India. 2014 Oct;62(10):43. No abstract available.

PMID:
25906521
46.

Pembrolizumab for the treatment of non-small-cell lung cancer.

Garon EB, Rizvi NA, Hui R, Leighl N, Balmanoukian AS, Eder JP, Patnaik A, Aggarwal C, Gubens M, Horn L, Carcereny E, Ahn MJ, Felip E, Lee JS, Hellmann MD, Hamid O, Goldman JW, Soria JC, Dolled-Filhart M, Rutledge RZ, Zhang J, Lunceford JK, Rangwala R, Lubiniecki GM, Roach C, Emancipator K, Gandhi L; KEYNOTE-001 Investigators.

N Engl J Med. 2015 May 21;372(21):2018-28. doi: 10.1056/NEJMoa1501824. Epub 2015 Apr 19.

47.

Rgg protein structure-function and inhibition by cyclic peptide compounds.

Parashar V, Aggarwal C, Federle MJ, Neiditch MB.

Proc Natl Acad Sci U S A. 2015 Apr 21;112(16):5177-82. doi: 10.1073/pnas.1500357112. Epub 2015 Apr 6.

48.

Targeted therapy for lung cancer: present and future.

Aggarwal C.

Ann Palliat Med. 2014 Jul;3(3):229-35. doi: 10.3978/j.issn.2224-5820.2014.06.01.

49.

Severe gingival enlargement with coexisting erosive lichen planus in severe chronic periodontitis patient.

Sharma A, Aggarwal C, Mathur VP, Sardana D.

Case Rep Dent. 2015;2015:538538. doi: 10.1155/2015/538538. Epub 2015 Mar 9.

50.

Cardiac Transplantation in the New Era.

Gass AL, Emaminia A, Lanier G, Aggarwal C, Brown KA, Raffa M, Kai M, Spielvogel D, Malekan R, Tang G, Lansman S.

Cardiol Rev. 2015 Jul-Aug;23(4):182-8. doi: 10.1097/CRD.0000000000000066. Review.

PMID:
25807107

Supplemental Content

Loading ...
Support Center